Targeting CD19 for diffuse large B cell lymphoma in the era of CARs: Other modes of transportation
Author:
Funder
Bayer Fund
EMD Serono
AbbVie
Bristol-Myers Squibb
AstraZeneca
Janssen Pharmaceuticals
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference62 articles.
1. Phase I trial of an anti-CD19 deglycosylated ricin a chain immunotoxin in non-Hodgkin’s lymphoma: effect of an intensive schedule of administration;Conry;J Immunother Emphasis Tumor Immunol,1995
2. Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study;Pulczynski;Blood,1993
3. Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyond;Katz;Leuk Lymphoma,2014
4. Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody;Hekman;Cancer Immunol Immunother,1991
5. A multicenter phase I study of inebilizumab, a humanized anti-CD19 monoclonal antibody, in Japanese patients with relapsed or refractory B-cell lymphoma and multiple myeloma;Ohmachi;Int J Hematol,2019
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Spotlight on ideal target antigens and resistance in antibody-drug conjugates: Strategies for competitive advancement;Drug Resistance Updates;2024-07
2. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10
3. In relapsed or refractory diffuse large B‐cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine;eJHaem;2023-11-30
4. How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B‐cell lymphoma?;Hematological Oncology;2023-11-08
5. Bispecific Antibodies in Hematological Malignancies: A Scoping Review;Cancers;2023-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3